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Abstract 
Background: The implementation of lockdowns in the UK during the COVID‑19 pandemic resulted in a system 
switch to remote primary care consulting at the same time as the incidence of domestic violence and abuse (DVA) 
increased. Lockdown‑specific barriers to disclosure of DVA reduced the opportunity for DVA detection and referral.
The PRECODE (PRimary care rEsponse to domestic violence and abuse in the COvid‑19 panDEmic) study will com‑
prise quantitative analysis of the impact of the pandemic on referrals from IRIS (Identification and Referral to Improve 
Safety) trained general practices to DVA agencies in the UK and qualitative analysis of the experiences of clinicians 
responding to patients affected by DVA and adaptations they have made transitioning to remote DVA training and 
patient support.
Methods/Design: Using a rapid mixed method design, PRECODE will explore and explain the dynamics of DVA 
referrals and support before and during the pandemic on a national scale using qualitative data and over four years of 
referrals time series data.
We will undertake interrupted‑time series and non‑linear regression analysis, including sensitivity analyses, on time 
series of referrals to DVA services from routinely collected data to evaluate the impact of the pandemic and associated 
lockdowns on referrals to the IRIS Programme, and analyse key determinants associated with changes in referrals.
We will also conduct an interview‑ and observation‑based qualitative study to understand the variation, relevance 
and feasibility of primary care responses to DVA before and during the pandemic and its aftermath.
The triangulation of quantitative and qualitative findings using rapid analysis and synthesis will enable the articula‑
tion of multiscale trends in primary care responses to DVA and complex mechanisms by which these responses have 
changed during the pandemic.
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Background
Domestic violence and abuse during the COVID‑19 
pandemic
The global incidence of domestic violence and abuse 
(DVA) has increased notably during the COVID-19 
pandemic in association with strict social distancing 
measures (lockdowns), widespread anxiety, increased 
economic precarity, and reduced access to support ser-
vices [1–7]. While lockdown measures are necessary 
from a wider public health perspective [8], shutting down 
or limiting usual routes to support and safety could have 
a detrimental impact on the health and wellbeing of peo-
ple affected by DVA and their families [9, 10].
Although DVA prevalence figures largely differ inter-
nationally due to variations in measurement techniques 
[11], even before the pandemic the incidence was high 
globally [11–13]. In the UK, according to the Office for 
National Statistics (ONS), 7.3% of women and 3.6% of 
men nationally have experienced DVA in a year [14] and 
life-time population prevalence is consistently higher for 
women seeking health care [15], including primary care 
[16]. Women experience more repeated and severe abuse, 
sexual violence, and coercive control [17].
DVA is a violation of human rights that damages health 
and wellbeing. It requires a multi-sectoral response, 
including a vital role of health care services in responding 
to affected patients [18–21]. A major part of this health 
care response is identification of people who are affected 
by abuse and enabling access to appropriate support to 
enhance their safety and improve their health outcomes. 
In the United Kingdom (UK), that specialist support 
largely comes from third sector DVA agencies.
Primary health care response to DVA
There are international [22] and national UK [23] guide-
lines for the healthcare of women affected by DVA, and a 
growing recognition of its impact on their health [24, 25]. 
Over the past decade, in line with guidelines, UK general 
practice has started to engage with DVA, with training of 
general practice teams in the identification, support and 
referral of female patients affected by abuse from a part-
ner/spouse or other adult in the household.
General practice can provide a safe and confiden-
tial place for disclosure and enquiry about abuse and a 
crucial link to further support from the specialist DVA 
sector. This engagement has a strong evidence base, par-
ticularly the landmark IRIS (Identification and Referral 
to Improve Safety) trial [26] and subsequent interrupted 
time series [27], showing effective implementation and 
cost-effectiveness [28]. The IRIS programme, which is 
facilitated and monitored by IRISi, a social enterprise 
[29], has been commissioned in 48 areas and has trained 
over 1,000 practices (> 12%) in England, Wales, the 
Channel Islands and Northern Ireland with over 20,500 
female patients referred from these practices in the past 
10 years.
The implementation of lockdowns in the UK resulted 
in the majority of medical consultations in primary care 
shifting to audio or video encounters with patients [30, 
31]. Lockdown-specific barriers to disclosure of abuse 
[32] and barriers to general practice consultations linked 
to the system switch to remote consulting [33] have 
occurred at the same time as the incidence of abuse 
has increased [34]. The overall drop in consultations 
[30] and diagnoses [35] during the pandemic has, how-
ever, reduced the opportunity for detection. DVA also 
remained easily hidden by the many varied presentations 
around common mental health problems linked to the 
pandemic [36, 37].
The necessary transition to remote clinical consulta-
tions has uncovered safety and confidentiality concerns, 
practical challenges and knowledge gaps about how 
general practice clinicians can ask about abuse, respond 
appropriately and provide ongoing support [38]. The 
requirement for additional skills and competencies for 
the management of telemedicine has also emerged. 
IRISi has developed and disseminated guidance [39] for 
general practices nationally on conducting safe remote 
consultations both directly and via the Royal College of 
General Practitioners (RCGP), National Health Service 
England (NHSE), and social media. The guidance raised 
awareness about the heightened risks and provided 
advice on overcoming barriers to enquiry, identification 
and referral to specialist services. Local IRIS provid-
ers are offering COVID-19-adapted online training to 
Discussion: Our findings will inform the implementation of remote primary care and DVA service responses as 
services re‑configure. Understanding the adaptation of clinical and service responses to DVA during the pandemic is 
crucial for the development of evidence‑based, effective remote support and referral beyond the pandemic.
Trial registration: PRECODE is an observational epidemiologic study, not an intervention evaluation or trial. We will 
not be reporting results of an intervention on human participants.
Keywords: COVID‑19 pandemic, Primary care, General practice, Domestic violence and abuse, Remote consultation, 
Referral, Mixed‑method protocol, Rapid qualitative analysis, Rapid synthesis, Interrupted‑time series analysis
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support implementation of the guidance and DVA gen-
eral practice work in general.
About PRECODE
Aims and objectives
In this paper we summarise the protocol for PRECODE 
(PRimary care rEsponse to domestic violence and abuse 
in the COvid-19 panDEmic: interrupted time series and 
qualitative study) which aims to understand the impact 
of the UK national COVID-19 lockdowns on general 
practice responses to DVA. Using a rapid mixed method 
design, the study will explore the impact of the pandemic 
on the number of patient referrals from IRIS trained gen-
eral practices to DVA agencies in the UK. It also aims to 
understand the experiences of primary care clinicians 
responding to patients affected by DVA during the pan-
demic and adaptations they have made transitioning to 
online DVA training and to remote DVA identification, 
support, and patient referral.
1.3.2. Research questions
To achieve these aims, the study will answer the follow-
ing research questions:
(1) What is the impact of the national COVID-19 lock-
downs in the UK on the referral rates of patients 
affected by DVA in practices that have had IRIS 
DVA training and a specialist referral pathway?
(2) How, if at all, have these practices adapted to online 
DVA training and to remote DVA identification, 
support, and patient referral?
The integration of quantitative and qualitative 
approaches (workstreams) will enable the articulation 
of multiscale trends in primary care responses to DVA 
and complex mechanisms by which these responses to 
patients have changed during the pandemic.
Patient and public involvement and engagement
An established patient and public involvement and 
engagement (PPI&E) group of women survivors of DVA 
(supporting the REPROVIDE research programme [40] 
and meeting quarterly) has advised on the development 
of the proposal and will be consulted regularly through-
out the duration of the study. We have also formed a 
dedicated PRECODE PPI&E group of survivors consist-
ing of women who have experienced DVA and who have 
been supported by a DVA specialist service and local 
IRIS programmes. The PRECODE PPI&E group will 
meet quarterly and will work in close collaboration with 
the research team advising on study design, conduct, 
analysis, interpretation of findings and dissemination. In 
addition, we will also consult an established male DVA 
survivor group that advises on the REPROVIDE pro-
gramme. All our PPI&E group members will have careful 
induction to ensure appropriate conduct, the safety and 
wellbeing of the group, and to enhance their engagement. 
The PPI&E meetings take place in a supportive and safe 
environment and are followed by de-briefing sessions. 
Members will be supported by their DVA organisations 
and will be also encouraged to seek additional support 
from our partner DVA agencies and from Bristol Medical 
School’s Centre for Academic Primary Care PPI&E facili-
tator [41].
Ethics and funding
The study received HRA (Health Research Authority) and 
Health and Care Research Wales (HCRW) Approval (20/
HRA/5873) and University of Bristol Faculty of Health 
Science Research Ethics Approval (113,044).
In addition, the University of Oxford, Medical Sci-
ences Inter-Divisional Research Ethics Committee 
(IDREC) granted amendment approval to our aligned 
study exploring the experiences of general practitioners 
with remote consultations in non-IRIS practices in the 
UK ‘R69839/RE003—Understanding GP (general practi-
tioner) perspectives on the safe and effective delivery of 
safeguarding’ to conduct a secondary analysis and inte-
grate findings with the PRECODE study.
PRECODE is a 12-month third sector-cross universi-
ties collaborative project and is funded by the UKRI (UK 
Research and Innovation) Rapid Response Call and the 
(MRC) Medical Research Council MR/V041533/1.
Methods and design
Quantitative workstream: impact of COVID‑19 social 
distancing measures (lockdowns) on referral rates 
of patients affected by DVA
Aims and objectives
We will analyse the numbers of referrals from general 
practices to the IRIS service to:
 (i) quantify the impact of the three national COVID-
19 lockdowns and social distancing restrictions on 
referrals to IRIS services during 2020 and 2021
 (ii) quantify the difference in the number of referrals 
during school holidays (periods when the num-
ber of IRIS referrals consistently dip) over differ-
ent years between 2017–2020 and contrast these 
to referrals during the national lockdowns in 2020 
and 2021
 (iii) determine the key factors significantly associated 
with increased referrals during school holidays 
and during the national lockdowns in the period 
between 2017–2021.
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Measurements and data collection
We will quantify the number of general practice refer-
rals of female patients to a local IRIS programme for 
specialist DVA support from March 2017 to Septem-
ber 2021. We will use routinely collected practice-level 
referral data from 33 sites where IRIS was commis-
sioned for at least 12 months before the UK announced 
its first national lockdown on the  23rd of March 2020. 
In line with our previously published work [42, 43] data 
will include anonymised daily individual-level data for 
referrals to the IRIS programme received by DVA spe-
cialist agencies from general practices across 33 sites 
between 24/03/2017- 22/9/2021 for female patients 
aged 16 and above, registered at a general practice.
It is estimated that 14,000 to 15,000 individual level 
referrals will constitute the final sample size, given 
that between  1st April 2017 and  1st April 2020 IRIS has 
received 4,934 referrals to the programme.
Statistical analysis
Two separate but related analyses will be completed as 
part of this workstream.
In the first analysis, we will evaluate the impact of the 
pandemic and associated lockdowns on referrals to the 
IRIS Programme (referrals to IRIS advocate educators 
in specialist DVA services) and compare these to the 
referrals during school holidays between 2017–2020. 
We will undertake interrupted-time series (ITS) [44] 
and non-linear regression analysis, including sensi-
tivity analyses, on time series of referrals to DVA ser-
vices from routinely collected practice level data across 
33 local authority or Clinical Commissioning Group 
(CCG) areas. We will fit different regression models to 
the data. For each regression model, we will calculate 
the Akaike Information Criterion (AIC) and the Bayes-
ian Information Criterion (BIC) to compare models and 
choose the best-fit model based on the smallest values 
of these quantities.
For the best-fit model, we will report incidence rate 
ratios (IRR) and 95% confidence intervals as indicators 
of change in referrals before and during the first, sec-
ond and third national lockdowns in 2020 and 2021 and 
during the school holidays in 2017/2018 and 2018/2019. 
This will allow us to quantify and contrast the impact 
and significance of the lockdowns and school holidays on 
the referrals. The periods of analysis will be: 01/4/2017–
31/12/2019 (initial analysis of the impact of school holi-
days); 24/3/2019–23/9/2020 (initial analysis of the impact 
of the first national lockdown), 24/3/2019–22/9/2021 
(final analysis of the impact of all three national COVID-
19 lockdowns). The final analysis will also allow us to 
track the effect of reopening society following the third 
national lockdown in 2021 after the roll-out of the 
COVID-19 vaccination campaign.
The second analysis will explore key determinants asso-
ciated with increased referral to the IRIS programme. We 
will explore whether these were different in the period 
before the pandemic (April 2017-December 2019) and 
during the pandemic (January 2020-December 2020). We 
will also explore the impact of training and guidance on 
referrals, given that within two weeks of the implemen-
tation of national social distancing/isolation policy and 
the shift to remote consultation, all IRIS practices were 
issued guidance and were offered COVID-19-specific 
online training to support implementation of the guid-
ance on safe remote consultations. We will have area-
level data on number of trainings that took place online. 
In a difference-in-difference analysis of referrals data, 
we will estimate the effect of that training. If possible, 
we will run an additional sensitivity analysis, using the 
local prevalence of DVA as reported to the police, based 
on the local Joint Strategic Needs Assessment (JSNA) or 
local office for policing and crime to adjust the ITS model 
in relation to incidence, once a chance in incidence may 
cofound that analysis of referral rates. Regression results 
for this second analysis will be presented as marginal 
effects or incidence rate ratios.
All quantitative analysis will be carried out using Stata 
MP 15.
Qualitative workstream: understanding adaptations 
to remote domestic abuse consultations, referral 
and training
Aims and objectives
We will conduct an interview- and observation-based 
qualitative study to understand:
 (i) the feasibility and utility of online training, the 
extent to which clinicians were able to imple-
ment national guidance and online training on safe 
remote consultations, support, and patient referral
 (ii) primary care clinicians’ views and experiences 
responding to affected patients during the pan-
demic and offer DVA referrals to specialist services
 (iii) organisational and individual practice adaptations 
and strategies addressing concerns and mitigating 
challenges around consultation safety, confidenti-
ality and efficacy as a result of transitioning to tel-
emedicine.
Sampling and recruitment
We will conduct interviews with professionals who are 
key in either providing support to patients affected 
by DVA or in reconfiguring how practices implement 
remote consultations. Participants will include (1) 
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practice managers and practice administrative staff 
who managed or facilitated the move to remote con-
sulting; (2) primary care clinicians who conducted 
routine and urgent primary care clinical consultations 
during the pandemic; (3) IRISi regional managers who 
oversaw and supported the implementation of the IRIS 
programme; and (4) IRIS advocate educators who (i) 
supported and provided on-going training for general 
practice teams to help them understand and respond to 
DVA during the pandemic (ii) received and responded 
to domestic abuse referrals for patients affected and 
provided specialist support to them.
Participants will be identified using purposive maxi-
mum variation sampling of professionals from up to 15 
IRIS trained general practices, interviewing approxi-
mately 30 primary care practice clinicians and 15 non-
clinical professionals (regional managers, advocate 
educators and practice managers). We will apply a 
multi-stage sampling framework. We will select up to 
eight sites where the IRIS programme is commissioned, 
usually a CCG or local authority area, during the first 
stage of sampling (area selection). The area selection 
will be informed by the initial analysis of referral rates/
patterns from the quantitative workstream examining 
referrals across different regions and variations in DVA 
referrals before and during the first UK pandemic wave. 
Area selection will be also informed by patient popu-
lation size and demographic and socio-economic com-
position. Sampling decisions will be guided by insights 
from IRISi regional managers either through formal 
interviews (see above) or via co-production with IRISi.
The second stage of sampling will take place within 
selected geographic areas and will be based on general 
practice referral rates. In partnership with local advo-
cate educators, who hold links with general practices 
and have local knowledge of the implementation of the 
IRIS programme in general practices, we will identify 
two dissimilar general practices (for example histori-
cally high and low referrers; uncharacteristically higher 
or lower referrers during the pandemic). Finally, our 
sampling approach, using a ‘snowballing’ sampling 
technique for the identification of individuals, will also 
consider the inclusion of participants from diverse 
demographic groups, those with diverse professional 
backgrounds and experiences, and those with different 
levels of involvement in the IRIS programme.
We will exclude professionals from the qualita-
tive study who were not actively in post for at least 
three months from the beginning of the first national 
lockdown (23/03/2020) (i.e. did not conduct patient 
consultations (primary care clinicians) or did not 
deliver at least one online training session (advocate 
educators)).
Local advocate educators will be asked to share details 
of the study (study summary and invitation letter) with 
the practice manager and a known primary care clini-
cian with experience in IRIS referral from each practice. 
The clinician will be asked to recommend another clini-
cian colleague from their practice with less involvement 
with IRIS to join the study. Participants will be asked 
to directly contact the researchers who will explain the 
study and will share the information sheet. If they indi-
cate to the researcher that they are willing to take part 
in an interview and meet the sampling and study inclu-
sion criteria, a suitable interview time will be arranged 
with the individuals directly or via the practice manager. 
Up to eight local advocate educators and regional man-
agers working with different sites and regions will also 
be invited to participate in an interview. We will seek 
consent from individuals to participate in the study and 
to being audio-recorded prior to the commencement of 
the interview.
We will also observe ten remotely delivered IRIS train-
ing sessions. Our sampling units for the observation will 
be general practices, not individual clinicians. Therefore, 
clinicians for the training observation will be recruited as 
a clinical team via the practice manager. Observed prac-
tices will be sampled to represent a mixture of practices 
by geographical location, demographic and socio-eco-
nomic composition of population, practice size and IRIS 
referral rates. Practice recruitment will be supported by 
IRISi regional managers and guided by local advocate 
educators. We will seek permission to observe training 
sessions from advocate educators, practice managers and 
clinicians.
Data collection
Semi-structured interviews will be conducted with gen-
eral practice clinicians, advocate educators, regional 
managers, and practice managers remotely (via phone 
or video call). The interviews will be focusing on experi-
ences of the management of DVA in primary care during 
the pandemic and views about the relevance, feasibility 
and utility of online DVA training. The semi-structured 
interviews will explore concerns with and experiences 
of asking (or not) about domestic abuse; relevance and 
availability of guidance; obstacles to and strategies for 
offering support and referral. Interviews with practice 
managers, regional managers and advocate educators will 
give insights into local adaptations and  organisational 
and practical barriers and facilitators to delivering online 
training. Interviews will be audio recorded and tran-
scribed verbatim.
We will also remotely (via video call) observe approxi-
mately ten online training sessions. The observations will 
document the context and dynamics of training sessions, 
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variations in training delivery, participants’ engagement 
with and reflections on the content and participants’ 
questions and concerns. Observations will be guided by 
an observation framework and will be summarised in 
detailed field notes.
Analysis plan
We will apply rapid qualitative analysis techniques 
adapted from McNall and Foster-Fishman [45] and 
Vindrola-Padros et  al. [46]. After each interview/obser-
vation the researcher will prepare a Rapid Assessment 
Procedure (RAP) summary sheet [47] to provide famil-
iarisation and research team access to the qualitative 
data. These short summaries will be shared among the 
research team in advance of full transcripts and field-
notes becoming available, enabling discussion of develop-
ing themes and iterative adaptation to topic guides. The 
qualitative research team will meet regularly to carry out 
group analysis of full transcripts and observation field-
notes and to develop an initial coding framework follow-
ing the Framework Method [48] as appropriate for rapid 
group analysis. Once the framework is agreed it will be 
applied across all transcripts and fieldnotes and data will 
be charted in a shared excel spreadsheet. At this stage, 
researchers will explore different framework categories 
for thematic insights, and will conduct further sub-analy-
ses as deemed relevant for answering the initial research 
questions, as well as responding to unanticipated topics 
within the data.
Synthesis of quantitative and qualitative workstreams
We will synthesise key initial findings from the qualita-
tive and quantitative workstreams. The synthesis will lead 
to new insights beyond those identified in each work-
streams. Exploratory and explanatory sequential mixed 
method data analysis [49, 50] will involve using the initial 
findings of the ITS to sample areas for interviews, based 
on variation in referral rates. Further ITS analysis will 
proceed in parallel with the qualitative interviews, lead-
ing to the synthesis stage in which we will triangulate the 
findings of the complete ITS with qualitative findings. 
We will explore temporal variation in the referral rates 
and variation between areas with interview data, generat-
ing hypotheses [51] to explain the variations. The initial 
findings of the ITS are likely to show a reduction in IRIS 
referrals from general practice, despite other external 
evidence (from national DVA helpline, domestic homi-
cide data, police reports) that incidence rose during the 
first and subsequent lockdowns. The interviews with 
primary care clinicians will explore possible explana-
tions for reduced referrals including reduced access to 
appointments and consultations, barriers to disclosure 
and perceptions of what DVA agencies can offer patients 
who do disclose. We will use timelining [52] to map cli-
nician experiences of asking about and referring (or not 
referring) patients affected by DVA. The timeline will 
correspond to the time window of the ITS analysis, but 
extended to the date of the interview, to capture changes 
in their consultation and referral behaviour and exter-
nal circumstances. Interviews with advocate educators, 
regional managers and practice managers on their expe-
rience of organising and delivering DVA support during 
the pandemic will help contextualise the ITS and clini-
cian interview data while also comparing and contrasting 
primary care clinician referrals with patient self-referrals 
to DVA agencies. The quantitative and qualitative work-
streams will be given equal significance.
We will contextualise the findings in the light of learn-
ing from parallel rapid research that has been undertaken 
during the pandemic and emergent policy and practice 
outputs relevant to the study. In particular, we will syn-
thetise our findings with an aligned study on the experi-
ences of non-IRIS general practitioners providing DVA 
support during the pandemic [53]. Our PPI&E groups’ 
insights regarding experiences of DVA survivors seeking 
support from primary health care and domestic violence 
services remotely will be informing the synthesis and 




The PRECODE study will combine quantitative and qual-
itative methods to explore and explain the dynamics of 
DVA referrals before and during the COVID-19 epidemic 
in the UK. We will be focusing on new evidence gaps 
created by the uncertainty about how general practices 
responded to (live) online DVA training and how they 
adapted their consultation methods in relation to DVA in 
the context of the COVID-19 pandemic. The importance 
of filling these gaps is driven by the prevalence of DVA 
globally and the UK [5, 13, 14, 34] with numbers likely 
to increase in the coming year(s), requiring an effective 
response from the NHS, particularly general practice.
The imposing of severe lockdown measures during 
the COVID-19 pandemic led to closure of face-to-face 
DVA services and consequential reduction in DVA refer-
rals in the UK (despite increased DVA prevalence). Evi-
dence-based, continual and effective remote support of 
DVA survivors and referrals to DVA service providers is 
crucial, as it is likely that even when social distancing is 
relaxed, a smaller proportion of general practice consul-
tations will be face-to-face [54]. Analysing the change in 
referrals and the adaptation of clinical responses to DVA 
during the pandemic is crucial in underpinning future 
planning, and this is the first mixed-method study to do 
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this on a national scale using qualitative interviews and 
over four years of referrals time series data.
Strengths and limitations
Key strengths of our study design are the rapid mixed 
method synthesis of diverse evidence sources. Both the 
quantitative and qualitative methodologies of the study 
are well-established and widely used technical frame-
works. The mixed method approach will allow for a 
broader and more granular exploration of the primary 
care response to DVA during the pandemic than quanti-
tative or qualitative methods alone. The triangulation of 
quantitative and qualitative findings using rapid analysis 
and synthesis methods successfully applied previously in 
the context of COVID-19 research [55, 56], will allow for 
a rapid assessment of the variation, relevance, feasibility, 
and safety of primary care responses to DVA before and 
during the pandemic and its aftermath.
Further strength lies in the multi-professional/multi-
agency collaborative approach linking general prac-
tice to the DVA sector. The study team members have 
led the field of domestic violence and health research 
in the UK for almost two decades, combining quantita-
tive (epidemiological studies, trials, surveys, economic 
analyses) with qualitative methods (cross-sectional and 
longitudinal interview and ethnographic studies) and 
systematic co-production of research with third sector 
partners. Team members have diverse expertise around 
the development, delivery and testing of DVA interven-
tions. Our landmark IRIS trial is the basis of a nationally 
commissioned training and advocacy programme link-
ing general practice to the DVA sector. Team members 
work to improve and promote the healthcare response to 
DVA in the UK and internationally, work in strong part-
nership with service users, the DVA sector, including 
close collaboration with IRISi, and the RCGP, and they 
seek opportunities to disseminate findings internation-
ally and to influence UK policy. Team members also lead 
evidence-based innovation in the health care response to 
DVA and are committed to influencing system change 
within health services and the DVA sector.
The study team will actively involve three service user 
expert groups. Throughout they will provide valuable 
insights into the perspectives and experiences of sur-
vivors. Finally, the study will benefit from including the 
views of different professional groups with expertise and 
experience in DVA and without a specific role in this 
area.
There are three possible limitations to this study. The 
first limitation concerns the possible generalisability 
and transferability of the findings to non-IRIS practices. 
Although we will ensure the diversity of recruited prac-
tices in terms of size, location and population, as well 
as the diversity of research participants, as the study is 
focusing on the pandemic responses of IRIS-trained gen-
eral practices to affected patients, the findings will not 
necessarily be applicable or relevant to non-IRIS trained 
practices (consisting the majority of general practices in 
the UK). We will mitigate this by integrating our work 
with parallel research exploring the experiences of gen-
eral practitioners with remote consultations in non-IRIS 
practices in the UK [53]. This triangulation work will sup-
port the development of resources and guidance to all 
clinicians working in primary care, with or without IRIS 
specific training. These resources will be developed with 
input from primary health care stakeholders from both 
IRIS and non-IRIS practices to ensure their applicability 
and relevance.
The second limitation is potential participation bias: 
the views of general practice professionals participat-
ing in the interview study might reflect the narratives of 
those individuals who may have been more experienced 
in or more engaged with the management of DVA iden-
tification and referral or more favourably disposed to the 
IRIS programme. Equally, advocate educators participat-
ing in the interview study might reflect the views of a 
self-selected group of professionals experienced in deliv-
ering DVA training and support.
Finally, the lack of patient research participant voice 
within the study will limit the interpretation of findings. 
As a result, although the perspectives of professionals 
will give indication of some of the barriers that might 
prevent patients from disclosing DVA in general practice, 
and the study will be guided by the perspectives of PPI&E 
members, our findings will not fully explain why some 
people affected by DVA do not seek or accept profes-
sional support during the pandemic. We will endeavour 
to interpret our findings in the light of relevant academic 
and policy outputs exploring survivor experiences of the 
pandemic.
Implications for practice
Enabling services to respond effectively to DVA is a UK 
policy priority [23, 57–59]. Our study will support the 
implementation of this policy by generating and dis-
seminating mixed-method evidence about the primary 
care response to DVA during the COVID-19 pandemic. 
Our findings will inform primary care and DVA service 
responses in the UK and other countries implementing 
remote clinical consultations, as they re-configure dur-
ing the pandemic and beyond, including the interface 
between DVA and the delivery of primary care, training, 
and support for patients identified by front-line practi-
tioners. We will formulate specific recommendations to 
improve online training and guidance on how primary 
care clinicians can safely and effectively address DVA in 
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remote consultations. The recommendations will con-
sider the needs of both IRIS and non-IRIS trained prac-
tices and ways in which DVA training and resources can 
be relevant and more widely available to general practices 
across the UK.
Given the highly sensitive nature of DVA research, we 
will adopt trauma-informed dissemination and data shar-
ing approaches, still consistent with open science [60, 61]. 
Findings from our synthesis will directly inform policy on 
training and support for general practices by establishing 
bi-directional communication with policy makers, com-
missioners, health service providers, service users, and 
third sector organisations. As co-produced research with 
IRISi, the RCGP and PPI&E members, we will rapidly 
funnel evidence to support policy and practice nation-
ally. Our evidence, resources and guidance will be open 
access and available to policymakers, commissioners, 
services, and front-line practitioners. We also expect to 
inform future national calls for evidence that feed into 
policy about DVA, local needs assessments and commis-
sioning of both health and frontline DVA programmes 
and services.
As with other health inequalities and adversities during 
the pandemic, although DVA has been made more visible 
in the last year, the health and domestic abuse sectors are 
struggling globally to re-configure services and develop 
new strategies. The study will drive inter-sectoral UK 
policy with relevance globally, by contributing resources 
and guidance for primary care clinicians addressing DVA 
using remote consultations. These will be vital in sup-
porting safe and effective care for affected patients as pri-
mary care re-formats post-pandemic.
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